Clinical Trial

Phio Pharmaceuticals Announces Positive Safety Monitoring Committee Recommendation to Advance INTASYL PH-762 Skin Cancer Study to Fourth Dose Escalation Cohort

-Phio's lead clinical siRNA compound PH-762 demonstrates supportive safety profile in third cohort, permitting escalation in next dose concentrationMarlborough, Massachusetts--(Newsfile…

9 months ago

Sport Clips Haircuts Continues to Shave the Way for Childhood Cancer Research with $1 Million Pledge

Los Angeles, California--(Newsfile Corp. - April 8, 2025) - Sport Clips Haircuts continues to lead in corporate social responsibility focused…

9 months ago

PhaseV to Present Transformative Use of AI for Clinical Development at Upcoming Events

Presentations to Highlight the Power of Advanced Machine Learning for Enhancing Trial Design, Execution and Analysis BOSTON, April 8, 2025…

9 months ago

ProofPilot Chief Strategy Officer Joseph Kim Joins Leadership Council of the Society for Clinical Research Sites

NEW YORK, April 8, 2025 /PRNewswire/ -- ProofPilot, the leading end-to-end Clinical Experience Platform (CXP), is proud to announce that its…

9 months ago

Volta Medical Appoints Bill Hoffman as Executive Chairman of the Board of Directors

MARSEILLE, France, April 8, 2025 /PRNewswire/ -- Volta Medical, a pioneering health technology company developing artificial intelligence (AI) solutions to assist…

9 months ago

Rapid Dose Therapeutics Provides Update on the Clinical Trial Development and the Commitment to NFL Funded Cannabinoid Research

Burlington, Ontario--(Newsfile Corp. - April 8, 2025) -  Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company"), a Canadian biotech…

9 months ago

Psyence BioMed Signs LOI with Southern Star Research to Expand Phase IIb Clinical Trial in Australia

New partnership strengthens Psyence BioMed's global clinical trial capabilities, accelerating the development of psilocybin-assisted therapy for adjustment disorderNew York, New…

9 months ago

Precision for Medicine Partners with SOPHiA GENETICS to Expand Biopharma Services with the SOPHiA DDM™ Platform and its Liquid Biopsy Capabilities

The partnership integrates advanced AI-driven analytics and clinical trial solutions, empowering biopharma companies to accelerate drug development and deliver targeted…

9 months ago

Belong.Life’s Advanced AI Technology Selected to Power New Menopause Support Solution

'Ask Elina' Harnesses Belong's Data and Expertise in Conversational AI to Help Women Navigate Menopause, Manage Symptoms and Explore Options NEW…

9 months ago

Cannabix Technologies to Attend Tennessee Safety and Health Conference to Exhibit Alcohol and Marijuana Breath Testing Technologies

VANCOUVER, British Columbia, April 07, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the…

9 months ago